Eosinophilic esophagitis improved by the discontinuation of sublingual immunotherapy for aeroallergens: a case report

Keyphrases

• Eosinophilic Esophagitis 100%
• Sublingual Immunotherapy 100%
• Aeroallergens 100%
• Esophagogastroduodenoscopy 28%
• Esophageal mucosa 28%
• Eosinophil Infiltration 28%
• Inflammation 14%
• Immune System 14%
• Omeprazole 14%
• Immune Response 14%
• Dysphagia 14%
• Esophagus 14%
• Chest Pain 14%
• Atopy 14%
• Sublingual 14%
• Eating 14%
• Oral mucosa 14%
• Allergen 14%
• Vomiting 14%
• Corticosteroid Treatment 14%
• Seasonal Variation 14%
• Meat 14%
• Monitoring Patients 14%
• Food Antigens 14%
• Symptom Improvement 14%
• IgE-mediated 14%
• Topical Corticosteroids 14%
• Esophageal Disorders 14%
• Macroscopic Examination 14%
• Alternaria 14%
• Tissue Eosinophils 14%
• Chronic Stimulation 14%
• Progressive Contact 14%
• Immune-mediated Inflammation 14%
• Injective 14%

Medicine and Dentistry

• Eosinophilic Esophagitis 100%
• Sublingual Immunotherapy 100%
• Aeroallergen 100%
• Eosinophilic 42%
• Esophagogastroduodenoscopy 28%
• Esophagus Mucosa 28%
• Prevalence 14%
• Omeprazole 14%
• Immunotherapy 14%
• Thorax Pain 14%
• Esophagus 14%
• Atopy 14%
• Corticosteroid Therapy 14%
• Case Presentation 14%
• Oral Mucosa 14%
• Plummer-Vinson Syndrome 14%
• Immunoglobulin E 14%
• Allergen 14%
• Topical Corticosteroid 14%
• Hypersalivation 14%
• Seasonal Variation 14%
• Food Antigen 14%
• Patient Monitoring 14%
• Immune System 14%
• Eosinophil 14%

Immunology and Microbiology

• Esophagitis 100%
• Sublingual Immunotherapy 100%
• Esophagus Mucosa 28%
• Prevalence 14%
• Allergen 14%
• Immunoglobulin E 14%
• Immunotherapy 14%
• Esophagus 14%
• Eosinophil 14%
• Mouth Mucosa 14%
• Atopy 14%
• Food Antigen 14%
• Alternaria 14%
• Immune System 14%